Harmony Biosciences Holdings, Inc. logo HRMY - Harmony Biosciences Holdings, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 2
SELL 2
STRONG
SELL 0
| PRICE TARGET: $43.00 DETAILS
HIGH: $50.00
LOW: $31.00
MEDIAN: $45.50
CONSENSUS: $43.00
UPSIDE: 42.62%

Profitability Ratios

Ratio Value
GP Margin 77.2%
EBIT Margin 26.5%
EBITDA Margin 29.4%
Operating Margin 24.0%
Pretax Margin 24.8%
Cont. Ops Margin 18.3%
Net Margin 18.3%
Bottom Line Margin 18.3%

Liquidity Ratios

Ratio Value
Current Ratio 3.60
Quick Ratio 3.58
Solvency Ratio 0.458
Cash Ratio 2.98

Valuation Ratios

Ratio Value
Price/Earnings
13.56
Hist. avg: 26.2
Peers avg: 16.9
PEG Ratio 1.74
Forward PEG 1.74
Price/Book 2.47
Price/Sales 2.48
Price/FCF 6.18
Price/Op Cash Flow 6.18

Debt Ratios

Ratio Value
Debt/Assets 0.1884
Debt/Equity 0.2753
Debt/Capital 0.2159
Long-Term Debt/Capital 0.1455
Financial Leverage 1.46

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.64
Operating Cash Flow Ratio 1.381
Operating Cash Flow/Sales 40.1%
Free Cash Flow/Operating Cash Flow 99.9%

Coverage Ratios

Ratio Value
Debt Service Coverage 1.96
Interest Coverage 14.2309
Short-Term Operating Cash Flow Coverage 4.01
Operating Cash Flow Coverage 1.45
Capital Expenditure Coverage 1123.22
Dividend + Capital Expenditure Coverage 1123.22

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 15.11
EPS 2.760
Debt/Share 4.4220
Cash/Share 13.49
Book Value/Share 15.14
Tangible BV/Share 13.58
Equity/Share 15.14
Operating Cash Flow/Share 6.056
Capital Expenditure/Share 0.005
FCF/Share 6.051

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.738
Earnings Before Tax/EBIT 1.032
Price/Fair Value 2.47
Debt/Market Cap 0.1093
Effective Tax Rate 26.2%
Enterprise Value Multiple 6.42